Remdesivir Beneficial for Subgroup Hospitalized With COVID-19
Reduced mortality seen among those receiving no or low-flow oxygen, but no benefit seen for those who were ventilated.
Diagnosis & Disease Information
Sanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month.
Lucira COVID-19 & Flu Home Test Now Available for OTC Use
The Lucira COVID-19 & Flu Home Test is available at a price of $34.99.
One in Seven Nonelderly Adults Have Past-Due Medical Debt
Of these individuals, nearly three-quarters owe some money to hospitals.
Viral, Symptom Rebound Common After COVID-19 Infection
The incidence of symptom rebound was higher in the nirmatrelvir plus ritonavir treatment group.
Nirmatrelvir-Ritonavir Effective Against Omicron BA.4, BA.5 SARS-CoV-2 Variant
What was the real-world effect of nirmatrelvir-ritonavir treatment in outpatients with early COVID-19 infection during the Omicron-predominant period of the pandemic?
Helping Clinicians Cope With Moral Distress Can Improve Patient Care
A central objective of addressing moral distress is to permit clinicians to effectively perform their professional functions and thus better help patients.
U.S. to Tighten Control of PFAS Chemicals in Drinking Water
Aim is to limit these chemicals — perfluoroalkyl and polyfluoroalkyl compounds — to near zero.
2020 to 2021 Saw Increase in Maternal Mortality Rates
Rate was higher for non-Hispanic Black versus non-Hispanic White women and also increased with age.
Axillary Lymphadenopathy Resolves at Mean 102 Days After COVID-19 Booster
No significant associations seen for age, vaccine booster type, history of breast cancer with time to resolution.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...